Literature DB >> 26861978

Lipid volume fraction in atherosclerotic plaque phantoms classified under saline conditions by multispectral angioscopy at near-infrared wavelengths around 1200 nm.

Daichi Matsui1, Katsunori Ishii1, Kunio Awazu2,3,4.   

Abstract

To identify high-risk atherosclerotic lesions, we require detailed information on the stability of atherosclerotic plaques. In this study, we quantitatively classified the lipid volume fractions in atherosclerotic plaque phantoms by a novel angioscope combined with near-infrared multispectral imaging. The multispectral angioscope was operated at peak absorption wavelengths of lipid in vulnerable plaques (1150, 1200, and 1300 nm) and at lower absorption wavelengths of water. The potential of the multispectral angioscope was demonstrated in atherosclerotic plaque phantoms containing 10-60 vol.% lipid and immersed in saline solution. The acquired multispectral data were processed by a spectral angle mapper algorithm, which enhanced the simulated plaque areas. Consequently, we classified the lipid volume fractions into five categories (0-5, 5-15, 15-30, 30-50, and 50-60 vol.%). Multispectral angioscopy at wavelengths around 1200 nm is a powerful tool for quantitatively evaluating the stability of atherosclerotic plaques based on the lipid volume fractions.

Entities:  

Keywords:  Angioscopy; Atherosclerotic plaque; Multispectral imaging; Near-infrared; Spectroscopy; Wavelengths around 1200 nm

Mesh:

Substances:

Year:  2016        PMID: 26861978     DOI: 10.1007/s10103-016-1879-x

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  17 in total

Review 1.  Intravascular ultrasound: novel pathophysiological insights and current clinical applications.

Authors:  S E Nissen; P Yock
Journal:  Circulation       Date:  2001-01-30       Impact factor: 29.690

2.  Refractive indices of water and ice in the 0.65- to 2.5-µm spectral range.

Authors:  L Kou; D Labrie; P Chylek
Journal:  Appl Opt       Date:  1993-07-01       Impact factor: 1.980

Review 3.  Hybrid intravascular imaging: current applications and prospective potential in the study of coronary atherosclerosis.

Authors:  Christos V Bourantas; Hector M Garcia-Garcia; Katerina K Naka; Antonios Sakellarios; Lambros Athanasiou; Dimitrios I Fotiadis; Lampros K Michalis; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2013-04-02       Impact factor: 24.094

4.  Optical coherence tomography--near infrared spectroscopy system and catheter for intravascular imaging.

Authors:  Ali M Fard; Paulino Vacas-Jacques; Ehsan Hamidi; Hao Wang; Robert W Carruth; Joseph A Gardecki; Guillermo J Tearney
Journal:  Opt Express       Date:  2013-12-16       Impact factor: 3.894

Review 5.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

Review 6.  Intravascular optical imaging technology for investigating the coronary artery.

Authors:  Melissa J Suter; Seemantini K Nadkarni; Giora Weisz; Atsushi Tanaka; Farouc A Jaffer; Brett E Bouma; Guillermo J Tearney
Journal:  JACC Cardiovasc Imaging       Date:  2011-09

7.  Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques.

Authors:  Jing Wang; Yong-Jian Geng; Bujin Guo; Tomas Klima; Birendra N Lal; James T Willerson; Ward Casscells
Journal:  J Am Coll Cardiol       Date:  2002-04-17       Impact factor: 24.094

8.  Noninvasive prediction of glucose by near-infrared diffuse reflectance spectroscopy.

Authors:  S F Malin; T L Ruchti; T B Blank; S N Thennadil; S L Monfre
Journal:  Clin Chem       Date:  1999-09       Impact factor: 8.327

9.  Relation of plaque lipid composition and morphology to the stability of human aortic plaques.

Authors:  C V Felton; D Crook; M J Davies; M F Oliver
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-07       Impact factor: 8.311

Review 10.  Molecular imaging of inflammation in atherosclerosis.

Authors:  Moritz Wildgruber; Filip K Swirski; Alma Zernecke
Journal:  Theranostics       Date:  2013-11-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.